NTLA - 3 Cathie Wood Stocks That Could More Than Double in 12 Months According to Wall Street
Cathie Wood and Wall Street analysts aren't always on the same page. Analysts are bearish, for example, on the three stocks that have helped the most in Wood's Ark Innovation ETF (NYSEMKT: ARKK) trouncing the market so far in 2023 .
However, there are some cases where analysts fully agree with her picks. Here are three Cathie Wood stocks that could more than double in 12 months, according to Wall Street.
Wood owns shares of Intellia Therapeutics (NASDAQ: NTLA) in two of her ETFs -- the flagship Ark Innovation ETF and the Ark Genomic Revolution ETF (NYSEMKT: ARKG) . And she has scooped up more of the stock in recent weeks for both ETFs.
For further details see:
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street